Jane Street Group, LLC Biocept Inc Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.24 - $0.62 $6,096 - $15,749
25,403 New
25,403 $8,000
Q2 2022

Aug 16, 2022
BUY
$0.88 - $2.27 $12,383 - $31,943
14,072 New
14,072 $13,000
Q4 2021

Feb 15, 2022
SELL
$3.43 - $4.22 $38,350 - $47,183
-11,181 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$3.39 - $4.34 $37,903 - $48,525
11,181 New
11,181 $45,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email